API	Active pharmaceutical ingredient
AS	Antisolvent
CLASC	Continuous liquid antisolvent crystallization
D10	The proportion of the distribution of particles with diameters smaller than the value is 10%
D50	Median diameter of the distribution of particles
D90	The proportion of the distribution of particles with diameters below the value is 90%
FEP	Fluorinated ethylene propylene
HPMC	Hydroxy propyl methyl cellulose
IM	Intramuscular
ITZ	Itraconazole
IVR	In vitro drug release
HPMC	Hydroxy propyl methyl cellulose
LAI	Long-acting injectables
LASC	Liquid antisolvent crystallization
MCR-CLASC	Microchannel reactor-based CLASC
NMP	N-methyl pyrrolidone
NaCMC	Sodium carboxymethylcellulose
PEA	Perfluoro alkoxy
PEEK	Polyether ether ketone
POL	Poloxamer
PSD	Particle size distribution
PVP K30	Polyvinyl pyrrolidone K30
PBS	Phosphate buffer saline of pH 7.4
PXRD	Powder X-ray diffraction
PSD	Particle size distribution
S	Solvent
SEM	Scanning electron microscopy
SC	Subcutaneous
SCT-CLASC	Secoya microfluidic crystallization technology-based CLASC
UPLC	Ultra-high-performance liquid chromatography
USFDA	US Food and Drug Administration
Vit E TPGS 1000	D-α-Tocopherol polyethylene glycol 1000 succinate